Cargando…
Early computational detection of potential high-risk SARS-CoV-2 variants
The ongoing COVID-19 pandemic is leading to the discovery of hundreds of novel SARS-CoV-2 variants daily. While most variants do not impact the course of the pandemic, some variants pose an increased risk when the acquired mutations allow better evasion of antibody neutralisation or increased transm...
Autores principales: | Beguir, Karim, Skwark, Marcin J., Fu, Yunguan, Pierrot, Thomas, Carranza, Nicolas Lopez, Laterre, Alexandre, Kadri, Ibtissem, Korched, Abir, Lowegard, Anna U., Lui, Bonny Gaby, Sänger, Bianca, Liu, Yunpeng, Poran, Asaf, Muik, Alexander, Şahin, Uğur |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioNTech and InstaDeep. Published by Elsevier Ltd.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9892295/ https://www.ncbi.nlm.nih.gov/pubmed/36774893 http://dx.doi.org/10.1016/j.compbiomed.2023.106618 |
Ejemplares similares
-
Neutralization of SARS-CoV-2 Omicron by BNT162b2 mRNA vaccine–elicited human sera
por: Muik, Alexander, et al.
Publicado: (2022) -
Omicron BA.2 breakthrough infection enhances cross-neutralization of BA.2.12.1 and BA.4/BA.5
por: Muik, Alexander, et al.
Publicado: (2022) -
Targeting the tumor vasculature with engineered cystine-knot miniproteins
por: Lui, Bonny Gaby, et al.
Publicado: (2020) -
Omicron BA.1 breakthrough infection drives cross-variant neutralization and memory B cell formation against conserved epitopes
por: Quandt, Jasmin, et al.
Publicado: (2022) -
Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine–elicited human sera
por: Muik, Alexander, et al.
Publicado: (2021)